Radiation Oncology Market Regional Analysis: North America, Europe and Asia-Pacific Forecast

Author : Ishika Pathare | Published On : 28 Oct 2026

The global radiation oncology market size was valued at USD 11.42 billion in 2025 and is projected to grow from USD 12.78 billion in 2026 to USD 31.41 billion by 2034, registering a CAGR of 11.9% during the forecast period from 2026 to 2034. North America dominated the radiation oncology market with a market share of 39.2% in 2025.

The radiation oncology market focuses on technologies, equipment, and treatments that use radiation to treat cancer. Radiation therapy uses high-energy radiation, commonly delivered through linear accelerators, to target and destroy cancer cells while limiting damage to nearby healthy tissues. It is frequently used alongside surgery, chemotherapy, and immunotherapy as part of a comprehensive cancer treatment plan.

The market includes external beam radiation therapy, internal radiation therapy, and advanced technologies designed to improve treatment accuracy. Growing demand for effective cancer care, rising healthcare expenditure, and technological progress are supporting the expansion of radiation oncology services worldwide.

Market Drivers

Rising Adoption of Radiotherapy

The growing use of radiation therapy across different cancer types is a major factor driving market growth. Radiotherapy can be used alone or in combination with other cancer treatments, depending on the patient's condition. Improvements in radiation delivery have also made it possible to target tumors more precisely while reducing exposure to surrounding healthy tissues.

Demand is increasing in developing countries as healthcare systems expand their cancer treatment facilities. Greater investment in radiotherapy equipment and treatment centers is expected to support wider access to cancer care.

Increasing Healthcare Expenditure

Rising healthcare spending is supporting investments in advanced cancer diagnosis and treatment. Hospitals and specialized cancer centers are increasingly adopting modern radiation therapy systems to improve treatment planning, accuracy, and patient care. Government funding, healthcare infrastructure development, and growing awareness of available cancer treatments are also contributing to market expansion.

Market Restraints

Shortage of Skilled Radiotherapy Professionals

A shortage of trained professionals remains a key challenge for the radiation oncology market. Advanced radiotherapy systems require skilled radiation oncologists, medical physicists, radiographers, and dosimetrists to plan and deliver treatment safely.

Limited access to trained staff can delay treatment and restrict the effective use of advanced equipment, particularly in countries with fewer cancer treatment facilities. Training, workforce development, and investment in specialized healthcare education will be important to address this challenge.

Market Opportunities

Technological Advancements in Radiotherapy

Technological innovation is creating significant opportunities in the radiation oncology market. Image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), stereotactic body radiotherapy (SBRT), volumetric-modulated arc therapy (VMAT), and proton therapy support more precise radiation delivery.

Improved imaging and treatment-planning software help clinicians target tumors more accurately and adjust radiation doses to the treatment area. These advances can reduce exposure to surrounding tissues and improve treatment efficiency. Continued development of advanced systems is expected to create opportunities for manufacturers, hospitals, and specialized cancer centers.

Market Segmentation

The radiation oncology market is segmented by therapy type, technology, application, and end user.

By therapy type, the market includes external beam radiation therapy and internal beam radiation therapy. External beam radiation therapy holds a leading position because it can treat various cancers using radiation generated outside the patient's body. Linear accelerators and advanced systems, including proton therapy equipment, are important technologies in this segment. Internal beam radiation therapy includes brachytherapy, in which a radioactive source is placed inside or near the treatment area.

By technology, the market includes image-guided radiation therapy, intensity-modulated radiation therapy, stereotactic radiotherapy, proton beam radiotherapy, three-dimensional conformal radiation therapy, volumetric-modulated arc therapy, and brachytherapy. These technologies support different treatment needs and help clinicians deliver radiation with greater precision.

By application, radiation oncology is used to treat prostate, breast, lung, head and neck, colorectal, and gynecologic cancers, among others. By end user, the market covers hospitals and clinics, cancer treatment centers, and research institutes.

Regional Insights

North America dominated the radiation oncology market in 2025, accounting for 39.2% of the global market. The region's growth is supported by high healthcare expenditure, a rising cancer burden, an aging population, and investment in advanced medical technologies. The presence of established cancer care organizations and ongoing research also supports the adoption of modern radiotherapy systems.

Europe is another important market, supported by advanced healthcare infrastructure, research capabilities, government initiatives, and investment in specialized treatments such as proton beam therapy.

Asia-Pacific is expected to experience strong growth as cancer treatment needs increase and healthcare systems invest in modern radiotherapy equipment. Government initiatives, expanding treatment infrastructure, and growing demand for advanced cancer care are contributing to regional development. Latin America and the Middle East and Africa also offer opportunities as healthcare providers expand cancer services and improve access to radiation therapy.

Key Players Analysis

Key companies operating in the radiation oncology market include:

• Varian Medical Systems Inc.

• IBA Radiopharma Solutions

• Elekta AB

• Accuray Incorporated

• BD

• Isoray Medical

• Nordion Inc.

• Mevion Medical Systems Inc.

• Curium Pharma

• ViewRay Technologies Inc.

These companies compete through product development, technology improvements, and efforts to expand access to radiation therapy systems. Advancements in adaptive treatment planning, image guidance, and workflow automation are important areas of industry development.

Conclusion

The radiation oncology market is expected to expand as the demand for cancer treatment increases and healthcare providers adopt more advanced radiation technologies. Growth in healthcare expenditure, improvements in treatment precision, and investment in cancer care infrastructure are creating opportunities across developed and emerging markets. Addressing shortages of trained professionals and expanding access to modern treatment facilities will remain important to the industry's long-term development.

Source: Straits Research – Radiation Oncology Market

About Us

Straits Research is a market intelligence and consulting organization that provides industry insights, market research reports, and strategic business analysis across a range of sectors. Its research supports organizations in understanding market trends, evaluating opportunities, and making informed business decisions.

Contact Us

Email: [email protected]
U.S.: +1 646 905 0080
U.K.: +44 203 695 0070